Dr. Jonathan Silverberg Lists Which Patients With AD Benefit Most From JAK Inhibitors

Jonathan Silverberg, MD, PhD, MPH, of George Washington University School of Medicine and Health Sciences, explains the benefits of using Janus kinase (JAK) inhibitors to treat patients with atopic dermatitis (AD). To read more, please click here.

Latest News

Among the cancer screenings you should regularly get after age 40, colorectal cancer, a stealthy disease that can have zero symptoms in its early stages, is one of the most important. Matthew Ng, MD, assistant clinical professor of surgery at the George Washington University Medical Faculty…
A panel of GW Cardiologists presented the inaugural GW Medicine Bicentennial Event, titled "Staying Heart Healthy." The panelists presented strategies to maintain a healthy heart and a healthy life.
The George Washington University is pleased to announce that Michael K. Rosner, MD, professor of Neurological Surgery, has been appointed to serve as the chair of the GW Department of Neurological Surgery. The department, known for excellence in patient care and for training generations of…